Cargando…
Treatment-resistant schizophrenia characterised by dopamine supersensitivity psychosis and efficacy of asenapine
Dopamine supersensitivity psychosis (DSP) frequently arises with long-term antipsychotic treatment and accounts for a significant proportion of treatment-resistant schizophrenia. The mechanism underlying DSP is thought to be a compensatory increase in dopamine receptor density in the striatum caused...
Autores principales: | Takao, Nagara, Murai, Toshiya, Fujiwara, Hironobu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051386/ https://www.ncbi.nlm.nih.gov/pubmed/33849886 http://dx.doi.org/10.1136/bcr-2021-242495 |
Ejemplares similares
-
Efficacy of Asenapine in Drug-resistant Psychotic Patients with Dopamine Supersensitivity Psychosis: Two Cases
por: Kanahara, Nobuhisa, et al.
Publicado: (2023) -
Supersensitivity Psychosis and Its Response to Asenapine in a Patient with Delusional Disorder
por: Rajkumar, Ravi Philip
Publicado: (2014) -
Chronic Treatment With Aripiprazole Prevents Development of Dopamine Supersensitivity and Potentially Supersensitivity Psychosis
por: Tadokoro, Shigenori, et al.
Publicado: (2012) -
Recent Discussions on Dopamine Supersensitivity Psychosis: Eight Points to Consider When Diagnosing Treatment-Resistant Schizophrenia
por: Kanahara, Nobuhisa, et al.
Publicado: (2021) -
Alterations of Dopamine D2 Receptors and Related Receptor-Interacting Proteins in Schizophrenia: The Pivotal Position of Dopamine Supersensitivity Psychosis in Treatment-Resistant Schizophrenia
por: Oda, Yasunori, et al.
Publicado: (2015)